1 results match your criteria: "Research Institute "Marqués de Valdecilla" (IDIVAL)[Affiliation]"
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.
Am J Transplant
June 2022
Hepato-Biliary-Pancreatic Surgery Unit and Transplantation, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Cancer is the leading cause of death after liver transplantation (LT). This multicenter case-control nested study aimed to evaluate the effect of maintenance immunosuppression on post-LT malignancy. The eligible cohort included 2495 LT patients who received tacrolimus-based immunosuppression.
View Article and Find Full Text PDF